Lithium Ascorbate for Alcohol Intoxication Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical treatments for chronic alcohol intoxication are inadequate, leading to irreversible damage and premature death, as they fail to effectively address the complex biochemical mechanisms involved in alcohol dependence and toxicity.
Innovation Solution
Lithium ascorbate is used as a prophylactic and therapeutic agent in doses of at least 5 mg/kg to regulate neuromediator balance and promote neuroadaptation, reducing toxicity and improving neurological and biochemical indices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antialcoholic pharmaceutical agents (sedatives, sleeping-draughts, antipsychotics, antidepressants) are used, then some symptomatic relief may be achieved, but they fail to effectively address the complex biochemical mechanisms of alcohol dependence and cause irreversible damage and premature death
Solution Approach 1:
The patent applies parameter changes by using lithium ascorbate at specific dosages (5-30 mg/kg) to alter the biochemical parameters of alcohol metabolism. This compound changes the metabolic pathway parameters, reducing toxic effects and preventing irreversible damage while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent employs a composite approach by combining lithium ions with ascorbic acid (vitamin C) to create lithium ascorbate. This composite compound leverages the neuroprotective properties of lithium and the antioxidant properties of ascorbic acid to synergistically address multiple mechanisms of alcohol toxicity simultaneously.
2Reliability
If high doses of lithium carbonate are used for psychiatric disorders, then neuromediator balance regulation is achieved, but the treatment complexity and potential toxicity increase
Solution Approach 1:
The patent changes the chemical form parameter of lithium from carbonate to ascorbate, which improves bioavailability and reduces treatment complexity. The ascorbate salt form allows for lower effective dosing (5-30 mg/kg vs. higher doses of carbonate) while maintaining neuromediator regulation efficacy.
Solution Approach 2:
The patent uses ascorbic acid as an intermediary compound that facilitates lithium delivery and enhances its therapeutic effects. Ascorbic acid acts as a mediator that improves lithium's neuroprotective action while reducing its potential toxicity and treatment complexity.
3Reliability
If lithium ascorbate is used at doses of at least 5 mg/kg, then neuroadaptation is promoted and neural tissue integrity is preserved, but the dosage requirement must be precisely controlled
Solution Approach 1:
The patent establishes specific dosage parameters (5-30 mg/kg) that optimize the balance between therapeutic effect and safety. This parameter specification enables precise dosage control in manufacturing and clinical application, ensuring neural tissue preservation while minimizing adverse effects.
Data Source
AI summary
The invention relates to medicine, particularly to the chemical and pharmaceutical industry and more particularly to the use of lithium ascorbate, in a dose of at least 5 mg/kg, as an agent for preventing and treating alcoholism and alcohol intoxication, and also providing protection of brain neurons and reducing demyelinating complications. The invention makes it possible to broaden the range of agents for this purpose.